Akèy › Twoub san › Distrik Columbia › Washington
Etid klinik pou Twoub san nan Washington, DC
5 etid pou Twoub san ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Childrens National Hospital, Washington D.C.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi lwen
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Ap rekriteFaz 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi lwen
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Etid Twoub san nan lòt vil
- Atlanta, GA10 etid
- Boston, MA10 etid
- Houston, TX9 etid
- Los Angeles, CA9 etid
- The Bronx, NY8 etid
- Nashville, TN7 etid
- New York City, NY7 etid
- Mountain View, CA6 etid
- Seattle, WA5 etid
- Durham, NC5 etid
- Portland, OR5 etid
- Greenville, NC5 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.